Abstract

25
A simple, sensitive and specific high-performance liquid chromatography method for Calibration curves were linear for BNIPDaoct concentrations ranging from 0.002 to 35 0.100 µmol L -1 . Matrix effects were observed and calibration curves were performed 36 using the different organ (spleen, liver, kidney, heart and lung) extracts. The method 37 was found to be specific, accurate (97.3-106.8% of nominal values) and precise for 38 intra-day (RSD < 1.9%) and inter-day assays (RSD < 7.2%) in all matrices. Stability 39 studies showed that BNIPDaoct was stable in all matrices after standing for 24 h at 40 room temperature (20 °C) or in the autosampler, and after three freeze/thaw cycles.
41
Mean recoveries of BNIPDaoct spiked in mice organs were > 88.4%. The LOD and
Introduction
51
Naphthalimides and bisnaphthalimides are cytotoxic DNA-intercalating compounds,
52
with well-established activity against several cancers [1] . Bisnaphthalimidopropyl 53 derivatives (BNIPs) linked to natural polyamines were designed and synthesized to 54 exhibit good cytotoxicity against cancer cells and parasites [2] [3] [4] [5] [6] [7] . In particular, 55 bisnaphthalimidopropyldiaminooctane (BNIPDaoct, Fig. 1 The biodegradable and biocompatible PLGA was chosen for the production of the 103 nanoparticles by a nanoprecipitation method described in detail elsewhere [11] . Briefly,
104
the polymer was dissolved in acetone at ~10 mg mL -1 to form the diffusing phase.
105
BNIPDaoct in DMSO was then added to reach 10% drug loading (w/w). This phase
106
(c.a. 1 mL) was added to the PVA 1% (w/v) dispersing phase (10-15 mL) and the prepared, using the same procedure without the addition of compound.
111
Particle size and distribution (polydispersity index, PI) were determined by dynamic 112 light scattering (DLS), using a Zetasizer Nano ZS laser scattering device (Malvern
113
Instruments Ltd., Malvern, UK) as described elsewhere [11] . Their mean size was 156 ± 114 3 nm, with a polydispersity index of 0.08 ± 0.03, and Zeta potential of -5.1 ± 0.7 mV. 
Preparation of biological matrices samples 131
Firstly, methanol was added to each organ at 1:2 (w/v, g/mL) for kidney, liver, and lung 132 or at 1:5 (w/v, g/mL) for heart and spleen, following homogenization using a high-
133
intensity IKA ultra-turrax. Next, the homogenates were dried under N 2 and then they 134 were reconstituted using mobile phase (1:5, w/v, g/mL 
Accuracy and precision
154
The accuracy and precision were determined by analyses of QC samples at three 
Limit of detection and quantification
163
The limits of detection (LOD) and quantification (LOQ) for each matrix were calculated 
216
Considering that monolithic columns can provide analyte separations using high flow 217 rates with an increase of pressure that can be withstand by any HPLC system, the flow 218 rate applied was studied, in order to maximize sample throughput and minimize mobile 219 phase consumption. The retention time decreased to 25.7, 33.7 and 50.2% when 220 applying 2.0, 1.5, and 1.0 mL min -1 , compared to the value obtained for 0.5 mL min -1 .
Hence, a flow rate of 1.5 mL min -1 was selected, considering that it afforded low 222 acetonitrile consumption and a pressure of 2.5 MPa within the HPLC system. The run 223 time was 6 min, with a retention time of 3.3 min for BNIPDaoct compound. 
Method validation and application to biological samples
225
The validation of the analytical HPLC method was carried out by evaluating its 226 selectivity, linearity, intra-day and inter-day precision and accuracy, stability, and 227 extraction recovery.
228
For selectivity, analyses of blank samples of all the matrices were performed as shown Accuracy and precision (inter-and intra-day) were also estimated. The intra-day 2 °C). BNIPDaoct showed stability in all matrices after this period as can be seen from 270 data in Table 3 
